Related Experiment Video
Updated: Jan 17, 2026
05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
1.0K
Challenges and Opportunities in State-of-the-Art Proteomics Analysis for Biomarker Development From Plasma
Panshak P Dakup1, Ivo Diaz Ludovico1, Youngki You1
1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.
Proteomics
|September 16, 2025
Summary
Extracellular vesicles (EVs) hold promise as disease biomarkers. Analyzing EV proteins directly in complex samples, rather than requiring pure EV isolation, offers a more viable path for biomarker discovery and development.
Area of Science:
- Biochemistry
- Cell Biology
- Biomarker Discovery
Background:
- Extracellular vesicles (EVs) are key in cell communication and can reflect disease states, making them potential biomarkers.
- Obtaining pure EVs from complex biofluids is difficult due to low abundance and contaminants, hindering biomarker development.
- Current EV purification methods have limitations, impacting recovery rates and data interpretation.
Purpose of the Study:
- To explore a novel approach for biomarker development by characterizing and quantifying EV proteins within complex biological samples.
- To shift the focus from achieving absolute EV purity to leveraging advanced technologies for biomarker discovery.
- To discuss the opportunities and challenges associated with analyzing EV proteins in complex matrices.
Main Methods:
- Leveraging mass spectrometry for deep and reproducible coverage of the EV proteome, even with sample impurities.
- Integrating advanced bioinformatics tools to refine the EV proteome landscape and identify potential biomarkers.
- Focusing on technological capabilities for EV protein analysis rather than solely on purification.
Main Results:
- Mass spectrometry enables robust proteomic profiling of EVs despite the presence of contaminants.
- The proposed approach facilitates the identification of novel EV biomarkers and streamlines validation processes.
- A paradigm shift towards analyzing EV proteins in complex samples can overcome current limitations in biomarker discovery.
Conclusions:
- Analyzing EV proteins directly in complex samples is a more practical and promising strategy for biomarker development than relying on pure EV isolation.
- Technological advancements, particularly in mass spectrometry and bioinformatics, are crucial for realizing the potential of EVs as biomarkers.
- This viewpoint highlights a transformative approach to EV biomarker discovery, emphasizing technological integration over absolute purity.
